Syncom Formulations (India) Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Syncom Formulations (India) Limited with three other
companies in this sector in INDIA :
Bal Pharma Limited
sales of 1.71 billion Indian Rupees [US$23.06 million]
Themis Medicare Limited
(2.02 billion Indian Rupees [US$27.17 million]
of which 100%
was Pharmaceuticals), and
Ortin Laboratories Ltd
(1.97 billion Indian Rupees [US$26.61 million]
Syncom Formulations (India) Limited reported sales of 2.06 billion Indian Rupees (US$27.70 million)
March of 2020.
increase of 10.0%
versus 2019, when the company's sales were 1.87 billion Indian Rupees .